The committee will have a public meeting on Thursday, May 22 in the Lecture Room, NAS Building, 2101 C Street NW. The morning session will consider conflict of interest questions in basic research and early phase clinical research. The afternoon session will examine conflict of interest issues in the development of clinical practice guidelines. Space in the meetin room is limited. Those who wish to attend the morning or afternoon sessions or both should register with Robin Parsell by email (rparsell@nas.edu) or phone (202-334-2360) and should indicate as soon as possible whether communications or other accommodations are needed.  The provisional agenda is posted below (Times may change).

INSTITUTE OF MEDICINE

COMMITTEE ON CONFLICT OF INTEREST IN

MEDICAL RESEARCH, EDUCATION, AND PRACTICE

Public Meeting -- May 22, 2008

Lecture Room – National Academy of Sciences

 2100 C Street NW, Washington, DC

Morning Session

CONFLICT OF INTEREST IN BASIC AND TRANSLATIONAL RESEARCH

7:30 Continental breakfast

8:15-8:35 Welcome, introductions, and chair’s statement

Bernard Lo, M.D., Committee Chair

8:35-9:00 Additional perspectives: professional society policies

Kenneth Kaushansky, M.D.

President, American Society of Hematology

Helen M. Ranney Professor and Chair, Department of Medicine

University of California, San Diego

9:00-10:10 Perspectives on financial relationships and conflicts of interest in basic and early-stage translational research: Part 1

Leslie Z. Benet, Ph.D.
Professor, Department of Biopharmaceutical Sciences
University of California San Francisco

Gail Cassell, Ph.D.
Vice President, Scientific Affairs and
Distinguished Lilly Research Scholar for Infectious Diseases
Eli Lilly and Company

Edward Benz, M.D.
President, Dana-Farber Cancer Institute

Discussion

10:10-10:30 Break

10:30-11:25 Perspectives on financial relationships and conflicts of interest in basic and early-stage translational research: Part 2

Hamilton Moses, III, M.D.
Chair, The Alerion Institute

Leo Furcht, M.D.

Past President, Federation of American Societies for Experimental Biology

Allen Pardee Professor and Head of Lab Medicine and Pathology

University of Minnesota School of Medicine

Discussion

11:25-Noon Financial disclosures and trust in health care professionals

Mark Hall, J.D.
Professor of Law and Public Health
Wake Forest University School of Law

Kevin Weinfurt, Ph.D. 
Associate Professor of Psychiatry and Behavioral Sciences

      and of Psychology and Neuroscience
Duke Clinical Research Institute

Discussion

Noon-1:00 Lunch for committee and speakers for morning and afternoon public sessions (Members Room)

 

Afternoon Session

CONFLICT OF INTEREST IN CLINICAL PRACTICE GUIDELINES

1:00-1:15 Welcome, introductions, and chair’s statement

Bernard Lo, M.D., Commitee Chair

1:15-2:00 Individual and organizational financial relationships with industry

Elizabeth Boyd, Ph.D.
Assistant Vice President for Research, Compliance and Policy
University of Arizona

Discussant: Data from the National Guidelines Clearinghouse
Mary Nix, M.S.
Health Scientist Administrator, National Guidelines Clearinghouse
Agency for Healthcare Research and Quality

Discussion

2:00-3:00 Organizational policies, practices, and challenges in developing and implementing conflict-of-interest and related policies

American Society of Clinical Oncology 
Dina Michels, Esq.

Vice President and General Counsel 

American Academy of Neurology
Murray Sagsveen, J.D.
General Counsel

American College of Cardiology
Sidney C. Smith, Jr., M.D.
Professor of Medicine and Director, Academic Center for Cardiovascular Disease

University of North Carolina

U.S. Preventive Services Task Force
Mary Barton, M.D., M.P.P.
Scientific Director, USPSTF
Agency for Healthcare Research and Quality

American Heart Association

John C. Ring, M.D.

Director, Policy Research and Development

Discussants:
Fran Visco, President, National Breast Cancer Coalition

Alvin Lever, M.A., CEO 

Sandra Zelman Lewis, Ph.D., Assistant Vice President

American College of Chest Physicians

Henry Masur, M.D., Chief, Department of Critical Care Medicine

NIH Clinical Center
 

TBD

3:00-3:20 Break

3:20-4:00 Continued discussion of organizational policies and practices

4:00-5:00 Systematic reviews and other strategies to protect against bias in guidelines development

Holger Schunemann, M.D., Ph.D.
Associate Professor of Medicine
University of Buffalo and Italian National Cancer Institute (Rome)

Discussion (all participants)

5:00-5:30 Public comment

5:30 Adjourn